Proposing a Superior Substitute for Cumbersome Prior Authorization

As insurance companies intensify their control measures on molecular and genetic testing, laboratories are finding themselves wrestling with the cumbersome process of prior authorizations. However, promising solutions are emerging in the form of Clinical Decision Support(CDS) systems, which hold the potential to foster cost savings and enhance patient outcomes.

Prior authorization is a process used by insurance companies to determine if they will cover a prescribed procedure, service, or medication. The process is meant to act as a checkpoint for cost control, ensuring that patients receive the most cost-effective care. However, the growing complexity and frequency of these authorizations have become a significant burden for healthcare providers, particularly laboratories that conduct molecular and genetic testing.

The backlash against prior authorization in healthcare is mounting, and there is a pressing need to explore more effective alternatives. The Centers for Medicare and Medicaid Services (CMS) recently took a step in the right direction by unveiling a rule to enhance and streamline this cumbersome process. The rule recognizes the need for change, acknowledging that prior authorization often hampers essential patient care due to convoluted payer requirements and protracted decision-making.

In addition to delaying needed care, prior authorization exacerbates medical provider burnout and drives up administrative costs for both providers and payers. This has prompted most state legislatures to also debate its overhaul. According to a survey conducted by the American Medical Association (AMA), physicians dedicate the equivalent of two full business days each week to navigating prior authorization requests — that diverts time they should be spending with patients.

Clinical Decision Support (CDS) systems offer a promising solution to prior authorization. In the field of radiology, the American College of Radiology’s long-standing appropriate use criteria (AUC) exemplifies how CDS systems for the optimization of use of advanced imaging services can provide a better alternative, fostering cost savings and improved patient outcomes.

Unlike prior authorization, the AUC/CDS program is transparent, evidence-based, can be implemented within electronic health records, and multi-specialty physician-led. The adoption of CDS systems has demonstrated tangible benefits in peer-reviewed literature, including reductions in inappropriate studies, more accurate diagnoses, reduced delays in accessing imaging, and enhanced health outcomes.

Based on real-world examples, CMS estimates that leveraging AUC could potentially save the Medicare program a staggering $700 million annually — underscoring the fiscal prudence of such alternatives. Moreover, with the advent of artificial intelligence (AI), the potential for CDS systems to serve as an alternative to prior authorization is further amplified.

Prior authorization processes pose significant challenges for healthcare providers, particularly laboratories. Alternatives like Clinical Decision Support (CDS) systems offer promising solutions. It will be crucial to explore and adopt such alternatives to foster cost savings, improve patient outcomes, and alleviate the burden on healthcare providers.